Ventas, Inc. (NYSE:VTR) has received an average rating of “Hold” from the seventeen analysts that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, eleven have assigned a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $65.12.
A number of research analysts have recently commented on VTR shares. Morgan Stanley set a $111.00 price target on Procter & Gamble and gave the company a “buy” rating in a report on Thursday, March 28th. BMO Capital Markets reiterated a “market perform” rating and issued a $73.00 price target on shares of Ventas in a research report on Wednesday, June 19th. Stifel Nicolaus set a $14.00 price objective on Oasis Petroleum and gave the stock a “buy” rating in a research report on Wednesday, June 19th. ValuEngine upgraded Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Friday, May 17th. Finally, Citigroup set a $14.00 price objective on General Electric and gave the company a “buy” rating in a research note on Wednesday, June 19th.
In related news, Chairman Debra A. Cafaro sold 68,084 shares of the firm’s stock in a transaction on Friday, June 14th. The stock was sold at an average price of $66.54, for a total transaction of $4,530,309.36. Following the sale, the chairman now owns 805,835 shares of the company’s stock, valued at approximately $53,620,260.90. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP T Richard Riney sold 29,702 shares of the firm’s stock in a transaction on Thursday, June 20th. The shares were sold at an average price of $70.45, for a total value of $2,092,505.90. Following the sale, the executive vice president now directly owns 163,488 shares in the company, valued at approximately $11,517,729.60. The disclosure for this sale can be found here. Insiders have sold 165,866 shares of company stock worth $11,323,058 in the last three months. 1.40% of the stock is currently owned by company insiders.
NYSE VTR traded down $1.98 on Friday, reaching $66.92. The company had a trading volume of 1,958,151 shares, compared to its average volume of 2,277,799. The firm has a market capitalization of $24.69 billion, a price-to-earnings ratio of 16.44, a PEG ratio of 4.50 and a beta of 0.28. The company has a quick ratio of 0.56, a current ratio of 0.56 and a debt-to-equity ratio of 1.05. The firm’s 50-day moving average is $67.76. Ventas has a 1 year low of $51.80 and a 1 year high of $73.74.
Ventas (NYSE:VTR) last announced its quarterly earnings data on Friday, April 26th. The real estate investment trust reported $0.99 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.96 by $0.03. Ventas had a return on equity of 4.04% and a net margin of 12.19%. The firm had revenue of $942.80 million for the quarter, compared to analysts’ expectations of $908.61 million. During the same period last year, the business posted $0.22 earnings per share. The firm’s revenue for the quarter was down .1% on a year-over-year basis. As a group, analysts forecast that Ventas will post 3.83 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, July 12th. Stockholders of record on Monday, July 1st were paid a dividend of $0.7925 per share. The ex-dividend date was Friday, June 28th. This represents a $3.17 dividend on an annualized basis and a dividend yield of 4.74%. Ventas’s dividend payout ratio (DPR) is currently 77.89%.
Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, university-based research and innovation centers, inpatient rehabilitation and long-term acute care facilities, and health systems.
Featured Story: What are benefits of a growth and income fund?
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.